Zepp Health Corporation Stock Price, News & Analysis

Zepp Health (NYSE: ZEPP), parent company of Amazfit, has acquired the core assets and intellectual property of Wild.AI, a women's wellness platform specializing in hormone-informed coaching for female athletes. The acquisition, completed in August, includes Wild.AI's technology and key leadership team members.

Wild.AI's platform helps women optimize their performance through cycle-based tracking and personalized insights for training, fueling, and recovery. The platform integrates with various wearables and provides hormone-aware symptom tracking and adaptive guidance. This acquisition follows a successful partnership that introduced a Wild.AI mini-app on Amazfit's Active 2 smartwatch.

Zepp Health plans to maintain the existing Wild.AI app while expanding its features across Amazfit devices globally, starting in the United States, while ensuring continued compatibility with third-party wearables.

Amazfit, owned by Zepp Health (NYSE: ZEPP), has announced a strategic partnership with elite trail runners Ruth Croft and Rosa Lara Feliu. This collaboration aims to enhance the company's sports watch development through athlete-driven innovation.

Croft, a decorated ultra-runner with victories in prestigious events like Western States and Mont Blanc Marathon, brings over five years of sports watch development experience. She will actively participate in product development and refinement. Feliu, an emerging European mountain runner, joins the team with notable achievements including a victory at Val d'Aran by UTMB.

Both athletes will utilize the T-Rex 3 GPS adventure watch and Helio Strap in their training. This partnership aligns with Amazfit's broader strategy of expanding its presence in performance sports, complementing existing partnerships with HYROX, Escape from Alcatraz Triathlon, and Bentonville Bike Fest.

Zepp Health (NYSE:ZEPP) reported strong Q2 2025 financial results, with revenue reaching US$59.4 million, marking a 46.2% year-over-year growth. The company narrowed its GAAP and adjusted net losses to US$7.7 million and US$6.16 million, improvements of 28.6% and 30.2% respectively compared to Q2 2024.

Key highlights include the successful launch of Amazfit Balance 2 and Amazfit Helio Strap, alongside strong performance from existing product lines. The company's gross margin was 36.2%, with operating expenses of US$27.6 million. Zepp ended Q2 with US$95.3 million in cash and expects Q3 2025 revenues between US$72.0-76.0 million, projecting 70-79% year-over-year growth.

The company strengthened its athlete ambassador program by welcoming NFL Pro Bowl running back Derrick Henry and Ultra Runner Rod Farvard, while achieving significant Prime Day sales growth, particularly in EMEA markets.

Amazfit, owned by Zepp Health (NYSE: ZEPP), has announced ultra runner Rod Farvard as its newest athlete ambassador. Farvard, known for completing challenging endurance races like Western States 100 and UTMB, holds a Fastest Known Time record on the John Muir Trail of 3 days, 16 hours, and 2 minutes.

Farvard will utilize the Amazfit T-Rex 3 smartwatch, Helio Strap, and Zepp App ecosystem in his training regimen, showcasing features including GPS accuracy, heart rate monitoring, and recovery tracking. He joins existing Amazfit ambassadors Yemaneberhan Crippa and Morgan Pearson, and will contribute to product testing, storytelling, and community events.

Amazfit, owned by Zepp Health (NYSE: ZEPP), has announced NFL star Derrick Henry as its newest athlete ambassador. The Baltimore Ravens running back, entering his 10th NFL season, will utilize Amazfit's smart wearables, particularly the T-Rex 3 smartwatch, to optimize his training, recovery, and performance.

Henry, a former NFL Offensive Player of the Year with two rushing titles and five Pro Bowl selections, will integrate Amazfit's technology and the Zepp App to monitor key health metrics, recovery indicators, and sleep quality. The partnership includes access to AI-powered insights, nutrition tracking, and the new BioCharge feature for monitoring daily energy levels.

Henry joins other notable Amazfit ambassadors, including Olympic gold medalist Gabby Thomas and various world-class athletes across different sports.

Zepp Health Corporation (NYSE:ZEPP), a global leader in smart wearables and health technology, has scheduled its second quarter 2025 financial results announcement for August 3, 2025. The company will host a conference call at 9:30 p.m. Eastern Time on the same day.

Investors can access the call through various toll-free and international dial-in numbers. A live and archived webcast will be available on the company's investor relations website. A replay of the call will be accessible until August 10, 2025.

Zepp Health (NYSE: ZEPP) has announced the launch of two new smart wearable devices under its Amazfit brand: the Balance 2 smartwatch ($299.99) and the Helio Strap ($99.99). The Balance 2 features a sapphire glass screen, 21-day battery life, and supports multiple sports including HYROX training, golf, and diving. It offers 170+ sport modes and advanced monitoring capabilities.

The Helio Strap, Amazfit's first screen-free tracker, provides continuous heart rate monitoring with a 10-day battery life. Both devices work together through the Zepp App, offering enhanced accuracy in performance tracking and recovery analysis with no additional subscriptions required. A bundle of both devices is available for $379.99, launching globally on June 24.

Zepp Health's Amazfit has launched the Active 2 Square smartwatch, a square variant of their Active 2 line featuring a 1.75-inch sapphire glass AMOLED display with 2,000 nits brightness. The device includes the BioTracker 6.0 PPG biosensor, enhanced PulsePrecision and RestoreIQ algorithms, and offers 160+ sports modes including HYROX Race Mode. Key features include offline maps with turn-by-turn navigation, 10-day battery life, Zepp Flow voice control, and integration with Wild.AI for women's health tracking. The Amazfit Active 2 Square is priced at $149.99 USD and is available immediately through Amazfit.com and Amazon.

Zepp Health Corporation (NYSE: ZEPP) reported Q1 2025 financial results with revenue of US$39 million, showing mixed performance. Amazfit-branded products grew 10.2% YoY, marking the first growth since Q1 2022. The company achieved a gross margin of 37.3%, up from 36.8% in Q1 2024. Key product launches included Amazfit Active 2 and Bip 6, which ranked among Amazon's top 10 smartwatches. The company maintained a strong cash position of US$104 million after repaying US$11.5 million in debt. For Q2 2025, management expects revenues between US$50-55 million, representing 23-35% YoY growth. Despite reporting a net loss of US$19.7 million in Q1, the company highlighted improvements in supply chain strategy, AI implementation, and strategic partnerships with athletes. The company has retired US$67.8 million of debt since early 2023 and continues its share repurchase program.